Skip to main content
Log in

Population screening for H. pylori not cost effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2014 Danish Krone

  2. H. pylori

  3. peptic ulcer disease

Reference

  • Hogh MB, et al. The cost effectiveness of Helicobacter pylori population screening-economic evaluation alongside a randomised controlled trial with 13-year follow-up. Alimentary Pharmacology and Therapeutics : 10 Mar 2019. Available from: URL: http://doi.org/10.1111/apt.15193

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Population screening for H. pylori not cost effective. PharmacoEcon Outcomes News 824, 24 (2019). https://doi.org/10.1007/s40274-019-5752-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5752-6

Navigation